• Development of workshops on research and clinical trials
  • Provision of information related to clinical trials published in open-access scientific journals
  • We adhere to the principles of open science

Join our discussion groups on preclinical-to-clinical transition opportunities for rare or poorly treated diseases in disadvantaged countries, beyond borders

The Classroom

Join this group to suggest training or workshop topics you’d like to attend

Training and Workshop Organization Group

Virtual Workshop Schedule

(coming soon)

Email us at info@sci-csi.org with the subject line: Clinical Research Workshop

Examples of clinical projects

Participate in the clinical trial project on Bryophyllum pinnatum for kidney stones

An interdisciplinary model of a clinical translation project in traditional medicine

The Myrciaria dubia (Camu-Camu) project

Camu-camu (Myrciaria dubia) is a small tree or shrub native to the Amazon rainforest, found mainly in Peru, Brazil, and Colombia.

A clinical study led by Dr. Jean-Pierre Routy aimed to determine whether taking capsules containing Camu Camu (CamuC™) as a supplement to antiretroviral therapy (ART) can reduce inflammation and immune activation.

Protocol: Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032)

Dr. Jean-Pierre Routy

Project location: Italy

The Padre Pio Cittadella: the project

The Cittadella is a large-scale project aimed at developing the therapeutic potential of plants growing within the perimeter of Padre Pio’s extensive garden.
Part of this major initiative is dedicated to the construction of a scientific laboratory to study medicinal plants and to serve as a leading reference center for the medical and scientific training of professionals working in the healthcare field.

Discussion group

Preclinical to clinical transition

Join our discussion groups on cosmetic clinical trials

Email us at info@sci-csi.org with the subject line: Cosmetic Clinical Trials

Join our discussion groups on preclinical-to-clinical transition opportunities for rare or poorly treated diseases in disadvantaged countries, beyond borders.

These groups allow you to participate in the following activities:

  • Exchange with researchers, clinicians, policy makers, and representatives from regulatory bodies;
  • Discover innovative models for validating and standardizing traditional therapies;
  • Identify partners for setting up clinical trials;
  • Discuss regulations governing the transition to human trials from simulated disease models in laboratory animals;
  • Actively contribute to the development of comprehensive healthcare solutions.

Clinical Trials of Oral Care Products

Join our discussion group

Email us at info@sci-csi.org with the subject line: Oral Care Clinical Trials

Translational objective of clinical trials

The ultimate goal of most clinical trials is to obtain approval of the tested treatment from the competent authorities. Regulatory approval allows the use of the treatment to be integrated into clinical practice.

This treatment can be administered as pills, injectables, compounded formulations, etc.

https://vitamall.ca/fr/blogs/news/tablets-vs-capsules-vs-softgels-vs-caplets-which-is-best

In France, the Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) is one of the highest authorities responsible for drug safety.

https://ansm.sante.fr/qui-sommes-nous/notre-perimetre/les-medicaments/p/medicaments-a-base-de-plantes-et-huiles-essentielles

If you have experience in preparing therapy approval applications with any regulatory authority, we need your guidance. Join us by writing to info@sci-csi.org.

If you have experience in preparing therapy approval applications with any regulatory authority, we need your guidance. Join us by writing to info@sci-csi.org.

Join our ethics committee projects

The role of a Research Ethics Committee (REC) or an Independent Ethics Committee (IEC) is to ensure the rights, safety, and well-being of all participants in clinical trials. Special attention must be given to clinical trials that recruit vulnerable participants.

Write to us at info@sci-csi.org, putting in the subject line: Working Group or Ethics Committee, or Working Group and Ethics Committee to join the SCI-Clinical Trials Without Borders team.